Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06216886 · ClinicalTrials.gov registry record · Phase 4
OnabotulinumtoxinA for Trigeminal Neuralgia
A Phase 4 study of Trigeminal Neuralgia, sponsored by Stanford University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT06216886 is a Phase 4 study of Trigeminal Neuralgia that is actively recruiting participants, run by Stanford University. The registered enrollment target is 20 participants, below the 5,768-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06216886, a Phase 4 study of Trigeminal Neuralgia, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
Conditions Studied
Interventions
- DRUG OnabotulinumtoxinA 100 UNT [Botox]
- DRUG Sodium Chloride 0.9% for Injection, Preservative Free
Study Locations (1)
California
- Meredith Barad - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-06-01 |
| Est. Completion | 2027-09-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06216886
The ClinicalTrials.gov registry entry for NCT06216886 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,768-participant average among 9 other Trigeminal Neuralgia trials with a reported enrollment target (100% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Trigeminal Neuralgia appearing as the primary indexed condition, and to 2 interventions - of which OnabotulinumtoxinA 100 UNT [Botox] is the first listed.
NCT06216886 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06216886 about?
NCT06216886 is a clinical study titled "OnabotulinumtoxinA for Trigeminal Neuralgia". A randomized controlled trial comparing Onabotulinumtoxin A to saline (placebo) for Trigeminal Neuralgia.
What is the current status of trial NCT06216886?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2024-06-01. Estimated completion is 2027-09-01.
What conditions does trial NCT06216886 study?
This clinical trial studies the following conditions: Trigeminal Neuralgia.
What interventions are being tested in trial NCT06216886?
The interventions under investigation include: OnabotulinumtoxinA 100 UNT [Botox] (DRUG), Sodium Chloride 0.9% for Injection, Preservative Free (DRUG).
Who is sponsoring clinical trial NCT06216886?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06216886 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Trigeminal Neuralgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
The Will Erwin Headache Research Center - Cluster Headache Study
RECRUITING
-
RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT
RECRUITING
-
Trigeminal Evoked Responses to Improve Rhizotomy
RECRUITING · Early Phase 1
-
Trigeminal Neuralgia Electrophysiology
RECRUITING
-
RAD 1501: A Trial of Virtual Cone Trigeminal Neuralgia Radiosurgery
ACTIVE NOT RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.